INFLAMMATORY BREAST CANCER STAGE III

Clinical trials for INFLAMMATORY BREAST CANCER STAGE III explained in plain language.

Never miss a new study

Get alerted when new INFLAMMATORY BREAST CANCER STAGE III trials appear

Sign up with your email to follow new studies for INFLAMMATORY BREAST CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo tested to shrink aggressive breast cancer before surgery

Disease control Recruiting now

This study is testing whether a combination of two drugs, trastuzumab deruxtecan and durvalumab, can shrink tumors before surgery in people with stage III inflammatory breast cancer that expresses the HER2 protein. The goal is to see if this treatment can eliminate all detectable…

Matched conditions: INFLAMMATORY BREAST CANCER STAGE III

Phase: PHASE2 • Sponsor: Filipa Lynce, MD • Aim: Disease control

Last updated Apr 01, 2026 23:11 UTC

INFLAMMATORY BREAST CANCER STAGE III

Get alerted when new INFLAMMATORY BREAST CANCER STAGE III trials appear

New drug duo tested to shrink aggressive breast cancer before surgery